Breast Cancer Metastasis-Suppressor 1-Like (BRMS1L) Peptide
BRMS1L
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all BRMS1L products
- BRMS1L (Breast Cancer Metastasis-Suppressor 1-Like (BRMS1L))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- GQTICIDKKD ECPTSAVITT INHDEVWFKR PDGSKSKLYI SQLQKGKYSI
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of BRMS1 L antibody,
Alternative Names: BRMS1L control peptide, BRMS1L antibody Blocking Peptide, Anti-BRMS1L Blocking Peptide, breast cancer metastasis-suppressor 1-like Blocking Peptide, BRMS1 Blocking Peptide, MGC11296 Blocking Peptide, BRMS1L, BRMSL-1, BRMSL 1, BRMSL-1 Blocking Peptide, BRMSL 1 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- BRMS1L (Breast Cancer Metastasis-Suppressor 1-Like (BRMS1L))
- Background
- The protein encoded by this gene shows sequence similarity to the human breast carcinoma metastasis suppressor (BRMS1) protein and the mammalian Sds3 (suppressor of defective silencing 3) proteins. This protein is a component of the mSin3a family of histone deacetylase complexes (HDAC).
- Molecular Weight
- 37 kDa
-
You are here:
